
Medicare May Cover AI Mental Health Devices as Nexalin Backs New Bill
Nexalin Technology (Nasdaq: NXL) has announced its support for the Health Tech Investment Act (S. 1399), a bipartisan legislation that would expand Medicare reimbursement for AI-enabled medical devices. The bill proposes a transitional reimbursement mechanism through New Technology Ambulatory Payment Classification codes for up to five years. The company’s upcoming…